Insider Shareholders with Direct Ownership of Chemomab Therapeutics Ltd. (CMMB)
This section provides a comprehensive overview of the insiders with direct ownership of Chemomab Therapeutics Ltd. (CMMB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Chemomab Therapeutics Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
George Adi Mor
Chief Scientific Officer |
0 | 332,475 | 324,775 $516,392 | 2 |
Nov 16, 2022
Reduced 50.0%
|
|
Neil Harris Cohen
Director |
12,409 | 2,409 | 10,000 $15,900 | 5 |
Nov 16, 2022
Reduced 19.41%
|
|
Dale R Pfost
Chief Executive Officer |
2,500 | 0 | 2,500 $3,975 | 1 |
Mar 14, 2022
Added 21.88%
|
|
Donald Marvin
Executive VP, CFO & COO |
1,750 | 0 | 2,000 $3,180 | 2 |
Mar 16, 2022
Added 11.11%
|
|
Joel Michael Maryles
Director |
1,433 | 0 | 1,433 $2,278 | 2 |
May 24, 2022
Added 2.25%
|
|
Nissim Darvish
Director |
1,200 | 0 | 1,200 $1,908 | 1 |
Mar 11, 2022
Added 50.0%
|